Vinati Organics Ltd
Incorporated in 1989, Vinati Organics Ltd manufactures specialty organic intermediaries
and Monomers[1]
- Market Cap ₹ 16,560 Cr.
- Current Price ₹ 1,597
- High / Low ₹ 2,040 / 1,412
- Stock P/E 38.0
- Book Value ₹ 283
- Dividend Yield 0.47 %
- ROCE 20.2 %
- ROE 15.4 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.6%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | 2,262 | |
| 614 | 601 | 1,180 | 1,493 | 1,429 | 1,666 | 1,613 | |
| Operating Profit | 415 | 353 | 435 | 573 | 471 | 582 | 650 |
| OPM % | 40% | 37% | 27% | 28% | 25% | 26% | 29% |
| 45 | 26 | 61 | 52 | 39 | 44 | 36 | |
| Interest | 2 | 1 | 2 | 3 | 5 | 2 | 1 |
| Depreciation | 33 | 43 | 45 | 59 | 73 | 89 | 96 |
| Profit before tax | 425 | 335 | 449 | 563 | 432 | 536 | 589 |
| Tax % | 21% | 20% | 23% | 26% | 25% | 24% | |
| 334 | 269 | 347 | 419 | 323 | 405 | 436 | |
| EPS in Rs | 32.48 | 26.20 | 33.72 | 40.78 | 31.16 | 39.09 | 42.04 |
| Dividend Payout % | 17% | 23% | 19% | 17% | 22% | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 5% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 7% |
| 3 Years: | -9% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 16% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 1,269 | 1,533 | 1,818 | 2,203 | 2,451 | 2,783 | 2,924 |
| 0 | 2 | 18 | 35 | 5 | 63 | 0 | |
| 163 | 188 | 243 | 335 | 374 | 423 | 370 | |
| Total Liabilities | 1,443 | 1,734 | 2,090 | 2,584 | 2,840 | 3,279 | 3,304 |
| 751 | 757 | 873 | 1,159 | 1,489 | 1,724 | 1,728 | |
| CWIP | 31 | 56 | 51 | 242 | 249 | 438 | 514 |
| Investments | 227 | 289 | 94 | 227 | 64 | 36 | 121 |
| 434 | 632 | 1,071 | 955 | 1,038 | 1,081 | 940 | |
| Total Assets | 1,443 | 1,734 | 2,090 | 2,584 | 2,840 | 3,279 | 3,304 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 416 | 219 | 127 | 515 | 332 | 458 | |
| -197 | -198 | -255 | -329 | -348 | -443 | |
| -109 | -3 | -47 | -62 | -108 | -16 | |
| Net Cash Flow | 109 | 18 | -175 | 124 | -125 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 72 | 106 | 104 | 82 | 102 | 96 |
| Inventory Days | 79 | 115 | 75 | 79 | 72 | 68 |
| Days Payable | 47 | 63 | 46 | 41 | 36 | 45 |
| Cash Conversion Cycle | 104 | 158 | 132 | 120 | 137 | 118 |
| Working Capital Days | 97 | 138 | 137 | 109 | 141 | 115 |
| ROCE % | 24% | 27% | 28% | 19% | 20% |
Documents
Announcements
-
Interview Of Ms. Vinati Saraf Mutreja, MD & CEO With CNBC - TV18.
19 Nov - MD Vinati Saraf Mutreja interviewed on CNBC-TV18 Nov 19, 2025 about results ended Sep 30, 2025.
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, Regarding Additional Investment In Veeral Organics Pvt. Ltd., Wholly Owned Subsidiary .
10 Nov - Subscribed 3,84,50,000 VOPL shares at par for ₹38.45 crore on Nov 10, 2025.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Nov
-
Intimation Of Contact Details Of Key Managerial Personnel Under Regulation 30(5) Of The SEBI (LODR) Regulations, 2015
5 Nov - CFO N.K. Goyal superannuated Nov 5; Gulshan K. Sakhuja appointed CFO effective Nov 6, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
5 Nov - Q2/H1 results: H1 standalone PAT Rs241.80cr; CFO retired Nov 5, Gulshan Sakhuja appointed Nov 6, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
Concalls
-
May 2025TranscriptPPTREC
-
Aug 2024TranscriptPPT
-
Aug 2024TranscriptPPT
-
May 2024TranscriptPPTREC
-
Feb 2024TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Feb 2021TranscriptPPT
-
Aug 2018TranscriptPPT
Product Offerings
The company’s product portfolio includes over 30 products across: [1]